Table 2.
Group | Thymus—Female (%) | Thymus—Male (%) | Spleen—Female (%) | Spleen—Male (%) |
---|---|---|---|---|
Normal | 0.17 ± 0.87 | 0.18 ± 0.01 | 0.18 ± 0.08 | 0.18 ± 0.08 |
Model | 0.11 ± 0.03 ** | 0.10 ± 0.09 ** | 0.14 ± 0.06 ** | 0.14 ± 0.01 ** |
PP-1 | 0.15 ± 0.01 # | 0.14 ± 0.01 *,# | 0.17 ± 0.03 Δ,*,# | 0.15 ± 0.07 *,# |
PP-2 | 0.15 ± 0.01 *# | 0.15 ± 0.03 *,# | 0.16 ± 0.12 *,# | 0.17 ± 0.01 *,# |
PP-3 | 0.16 ± 0.07 Δ,## | 0.14 ± 0.05 **,# | 0.15 ± 0.34 ** | 0.16 ± 0.01 *,# |
PPM-1 | 0.14 ± 0.04 ΔΔ,**,# | 0.18 ± 0.08 ## | 0.16 ± 0.09 *,# | 0.17 ± 0.09 ## |
PPM-2 | 0.19 ± 0.07 Δ,*,## | 0.16 ± 0.06 *,# | 0.19 ± 0.05 Δ,*,# | 0.16 ± 0.03 *,# |
PPM-3 | 0.17 ± 0.11 ## | 0.16 ± 0.03 *# | 0.19 ± 0.08 ΔΔ,# | 0.15 ± 0.04 *,# |
The irradiation dose was 6 Gy. * p < 0.05 and ** p < 0.01 compared with the normal group; # p < 0.05 compared with the model group and ## p < 0.01 compared with the model group; Δ p < 0.05 compared with the male group in the same indicator and ΔΔ p < 0.05 compared with the male group in the same indicator (mean ± SD, n = 6).